Content about Ranibizumab

August 13, 2012
FDA approves Genentech's Lucentis for diabetic macular edema

Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

July 27, 2012
FDA panel recommends new approval for Genentech eye drug

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

February 11, 2011
Lucentis improves vision among diabetes patients in trial

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

August 31, 2010
FDA expedites review of Alimera's Iluvien

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....

August 25, 2010
Novartis completes purchase of Alcon stock

Novartis on Thursday announced that it has completed its purchase of Alcon stock from Nestle,...

June 22, 2010
FDA approves Lucentis for vision loss-related disease

The Food and Drug Administration has approved a drug made by Genentech for treating a...

May 2, 2010
Study: Combination therapy may improve diabetic macular edema

A combination of a biotech drug and laser treatment may improve vision in patients with...

© 2013 Drug Store News. All Rights Reserved.